Related Experiment Videos

Angiotensin II receptors on colorectal carcinoma cells

D Kucerová1, B Zelezná, E Sloncová

  • 1Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Praha.

International Journal of Molecular Medicine
|December 22, 1998
PubMed

Insights

Colorectal cancer cells possess angiotensin II receptors, primarily of the AT2 type. Cell differentiation did not significantly alter the binding capacity of these angiotensin receptors.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Colorectal carcinoma is a significant global health concern.
  • The role of the renin-angiotensin system in cancer is an emerging area of research.
  • Angiotensin II receptors (AT1R and AT2R) are implicated in various cellular processes.

Purpose of the Study:

  • To investigate the presence and subtype of angiotensin II receptors on colorectal cancer cells.
  • To determine if cellular differentiation affects angiotensin receptor expression or binding capacity.

Main Methods:

  • Utilized three human colorectal carcinoma cell lines.
  • Performed binding assays using 125I-labelled angiotensin II.
  • Employed receptor-specific ligands to differentiate between AT1 and AT2 receptor subtypes.

Main Results:

  • Angiotensin II receptors were detected on all tested colorectal cancer cell lines.
  • The predominant angiotensin receptor subtype found on these cells was AT2.
  • Butyrate-induced differentiation did not lead to significant changes in the binding capacity of angiotensin receptors on tumor cells.

Conclusions:

  • Colorectal cancer cells express angiotensin II receptors, predominantly of the AT2 subtype.
  • The expression of AT2 receptors on colorectal cancer cells may represent a potential therapeutic target.
  • Further research is warranted to explore the functional role of AT2 receptors in colorectal tumorigenesis.

Related Concept Videos